+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment



Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment



American Journal of Tropical Medicine and Hygiene 75(6): 1074-1077



A 35-year-old man with a 19-year history of slowly evolving diffuse cutaneous leishmaniasis was treated with oral miltefosine, 50 mg three times a day. The patient responded after four months of miltefosine treatment with clearance of all nodular lesions and plaques from the entire body surface and had negative slit-skin smears and cultures for Leishmania. However, two months after stopping miltefosine, skin lesions reappeared and parasites were observed in samples. The relapsed lesions did not respond to an additional two-month course of miltefosine. No laboratory or clinical adverse events to miltefosine were observed. Parasites from skin lesions were cultured and identified as Leishmania (Leishmania) mexicana by isoenzyme electrophoresis.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 012883992

Download citation: RISBibTeXText

PMID: 17172368


Related references

Transient Success Using Prolonged Treatment with Miltefosine for a Patient with Diffuse Cutaneous Leishmaniasis Infected with Leishmania mexicana mexicana. American Journal of Tropical Medicine and Hygiene 88(1): 153-156, 2013

Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana. American Journal of Tropical Medicine and Hygiene 88(1): 153-156, 2013

Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome. Tropical Medicine and International Health 4(12): 801-811, 1999

Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome. Tropical Medicine and International Health 4(12): 801-811, 1999

Cutaneous leishmaniasis in amazonia brazil the 1st record of a case of cutaneous leishmaniasis caused by 2 parasites leishmania braziliensis braziliensis and leishmania mexicana amazonensis. Revista do Instituto de Medicina Tropical de Sao Paulo 26(5): 272-275, 1984

Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis. Journal of Venomous Animals and Toxins including Tropical Diseases 13(3): 598-606, 2007

Molecular karyotype characterization of Leishmania panamensis, Leishmania mexicana, and Leishmania major-like parasites: agents of cutaneous leishmaniasis in Ecuador. American Journal of Tropical Medicine and Hygiene 48(5): 707-715, 1993

Experimental cutaneous leishmaniasis. 3. Comparative pathology of infection by Leishmania brazilensis, Leishmania mexicana, and Leishmania tropica in laboratory animals. Revista do Instituto de Medicina Tropical de Sao Paulo 14(1): 12-29, 1972

Inbred mice as model hosts for cutaneous leishmaniasis 1. resistance and susceptibility to infection with leishmania braziliensis leishmania mexicana and leishmania aethiopica. Annals of Tropical Medicine and Parasitology 78(1): 25-34, 1984

Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major. Experimental Parasitology 148: 49-55, 2015

Cutaneous leishmaniasis in Amazonia. Report of the 1st human case of mixed infection, determined by 2 different Leishmania species: Leishmania brasiliensis and Leishmania mexicana amazonensis. Revista do Instituto de Medicina Tropical de Sao Paulo 26(5): 272-275, 1984

Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis. Revista Da Sociedade Brasileira de Medicina Tropical 41(4): 424-427, 2008

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial. Plos Neglected Tropical Diseases 4(12): E912, 2010

Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis. Antimicrobial Agents and ChemoTherapy 53(12): 5108-5113, 2009

Preliminary study towards a novel experimental model to study localized cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana. Revista do Instituto de Medicina Tropical de Sao Paulo 54(3): 165-169, 2012